• SENSEX 74,315.61
    1,533.72 (+2.11%)
  • BANKNIFTY 55,316.00
    -165.05 (--0.30%)
Back

Corporate News

Emcure Pharmaceuticals to review quarterly results at board meeting November 3, 2026
14-Oct-2026, 05:37

Emcure Pharmaceuticals Limited will hold a board meeting on November 3, 2026, to approve the unaudited financial results for both standalone and consolidated entities for the quarter and half-year ended September 30, 2026, according to a regulatory filing with the National Stock Exchange of India and BSE Limited. The trading window for company insiders has been closed since October 1, 2026, and will remain closed until November 5, 2026.